Welcome
About Victoza®
Executive Bios
Backgrounders
Press Releases
Image Gallery
Featured Video
Annual Report
Subscription Service
Media Contacts
Victoza®, the first once-daily human glucagon-like peptide-1 (GLP-1) analog approved for the treatment of type 2 diabetes is now available in the U.S.
Norditropin® FlexPro® (somatropin [rDNA origin] injection), a pre-filled injection pen to be used by children and adults with growth hormone disorders, has a user friendly design making it easy to learn and use. Available in 5mg/1.5 ml, 10mg/1.5 ml and 15mg/1.5 ml pens.
Novo Nordisk leaps ahead in overall ranking and is recognized for its mission to change diabetes.
Novo Nordisk has donated much needed funds and medical supplies to aid in the humanitarian efforts in Haiti.
We are pleased to report financial, social and environmental performance for 2009. The 2009 Annual Report accounts for our performance during the year - with financial and non-financial information and data in one inclusive report.
Our Media Relations team is ready to help you get all the information you need about Novo Nordisk.
Actors, Olympia Dukakis and Louis Zorich, partner with Novo Nordisk, to launch Ask.Screen.Know., a campaign to increase awareness and utilization of the Medicare diabetes screening benefit.